February 11, 2020
First Drug Approved by FDA to Treat Children’s Peanut Allergies Pioneered at Arkansas ...
Groundbreaking Research Began at ACRI, Continues 18 Years Later as Treatment Moves to Patients
Read More
November 18, 2019
![]()
Gregory Albert, MD Invested into the Lee and Bob Cress Endowed Chair in Pediatric Neurosurgery
Gregory Albert, MD Invested into the Lee and Bob Cress
Endowed Chair in Pediatric Neurosurgery
Read More
November 12, 2019
Arkansas Children’s Research Institute Joins NIH-Funded Research Network Addressing ...
Children with rare inflammatory diseases that prevent them from eating many foods will have the backing of an NIH-funded research network on their side, as Arkansas Children’s Research Institute (ACRI) joins a $7.75 million clinical research project addressing eosinophilic gastrointestinal diseases (EGIDs).
Read More
November 06, 2019
Arkansas Children’s Research Institute Awarded More Than $516,000 from NIH to Participate ...
Arkansas Children’s Research Institute (ACRI) is participating in a wide-ranging initiative to address addiction after the National Institutes of Health (NIH) awarded two of its researchers $516,375 to study how prenatal exposure to opioids and other drugs affects children’s brain development.
Read More
October 18, 2019
ACH Named Certified Duchenne Care Center by Parent Project Muscular Dystrophy
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), named Arkansas Children's Hospital as the 28th Certified Duchenne Care Center (CDCC).
Read More
October 17, 2019
Arkansas Children’s Promotes Hilbun to Chief Strategy Officer for System
Arkansas Children’s Inc. has promoted Ashlie Hilbun, EdD, CFRE, to the position of senior vice president and chief strategy officer, leading planning efforts, advancing business strategy and overseeing strategic marketing for the state’s only pediatric health system.
Read More